| abstract |
Novel cromolyn analogs useful as imaging agents for detecting atherosclerotic plaques and for treating atherosclerosis and Alzheimer's Disease, and methods of making the cromolyn analogs, are disclosed. The cromolyn analogs have the general formula: n n n n n n n n n n wherein: X is OH, C 1 -C 6 alkoxyl; Y and Z are independently selected form a C 1 -C 6 alkyl, C 1 -C 6 alkoxyl, halogen, un-substituted or C 1 -C 6 substituted amine, 18 F, 19 F, or H; and n is 1, 2, or 3; and wherein for structure (I), if n are both 1 and Y and Z are both H and X is OH. |